Literature DB >> 7622919

Soluble interleukin-6 receptor in patients with severe sepsis.

F Zeni, B Tardy, M Vindimian, P Pain, P Gery, J C Bertrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7622919     DOI： 10.1093/infdis/172.2.607

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  2 in total

1.  Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha.

Authors:  V Modur; Y Li; G A Zimmerman; S M Prescott; T M McIntyre
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 2.  Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19.

Authors:  Elizabeth Leung; Ryan L Crass; Sarah C J Jorgensen; Sumit Raybardhan; Bradley J Langford; W Justin Moore; Nathaniel J Rhodes
Journal:  Clin Pharmacokinet       Date:  2021-12-11       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.